A CANNABIS-based drug that relieves the symptoms of multiple sclerosis is expected to be available on prescription by the end of the year.
GW Pharmaceuticals said Sativex, which contains extracts from whole cannabis plants, is on track for release, subject to approval by the Medicines and Healthcare Products Regulatory Agency.
Because it contains can-nabis, Sativex would require a change in the law, but Home Secretary David Blunkett has indicated he would be willing to make an amendment if the drug was approved
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article